| Linderalactone |
Influence on cell viability |
MTT |
1.60 µM |
A549 |
Homo sapiens |
|
|
|
| Linderalactone |
Influence on cell viability |
MTT |
3.20 µM |
A549 |
Homo sapiens |
|
|
|
| Linderalactone |
Influence on cell viability |
MTT |
6.25 µM |
A549 |
Homo sapiens |
|
|
|
| Linderalactone |
Influence on cell viability |
MTT |
12.50 µM |
A549 |
Homo sapiens |
|
|
|
| Linderalactone |
Influence on cell viability |
MTT |
25.00 µM |
A549 |
Homo sapiens |
|
|
|
| Linderalactone |
Influence on cell viability |
MTT |
50.00 µM |
A549 |
Homo sapiens |
|
|
|
| Linderalactone |
Influence on cell viability |
MTT |
100.00 µM |
A549 |
Homo sapiens |
|
|
|
